The Effect of Desensitization Protocols on Human Splenic B-Cell Populations In Vivo
Open Access
- 1 February 2007
- journal article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 7 (2), 402-407
- https://doi.org/10.1111/j.1600-6143.2006.01632.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Intravenous Gammaglobulin (IVIG): A Novel Approach to Improve Transplant Rates and Outcomes in Highly HLA-Sensitized PatientsAmerican Journal of Transplantation, 2006
- A Comparison of Plasmapheresis Versus High-Dose IVIG Desensitization in Renal Allograft Recipients with High Levels of Donor Specific AlloantibodyAmerican Journal of Transplantation, 2006
- Conquering absolute contraindications to transplantation: Positive-crossmatch and ABO-incompatible kidney transplantationSurgery, 2005
- Antigen-selected, immunoglobulin-secreting cells persist in human spleen and bone marrowBlood, 2004
- CD138 (Syndecan-1), a Plasma Cell MarkerAmerican Journal of Clinical Pathology, 2004
- Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients1Transplantation, 2003
- ABO-incompatible kidney transplantation using both A2 and non-A2 living donorsTransplantation, 2003
- Desensitization and Subsequent Kidney Transplantation of Patients Using Intravenous Immunoglobulins (IVIg)American Journal of Transplantation, 2002
- Effects of specific anti‐B and/or anti‐plasma cell immunotherapy on antibody production in baboons: depletion of CD20‐ and CD22‐positive B cells does not result in significantly decreased production of anti‐αGal antibodyXenotransplantation, 2001
- Regulation of Human B-Cell Activation and AdhesionAnnual Review of Immunology, 1991